Visual Feedback in Lower Limb Rehabilitation

Institute of Hospitalization and Scientific Care (IRCCS)

Status: Completed

Conditions: Brain Injuries; Brain Injuries, Traumatic; Brain Injuries, Vascular

Treatments: Device: OMEGO®

Study type: Interventional

Funder types: Other

Identifiers

NCT05179330

3515

Details and patient eligibility

About

Severe Acquired Brain Injury (sABI) is defined as "an encephalic impairment that occurs after birth and is not related to a congenital or degenerative disease.

This impairment may be temporary, or permanent, and cause partial or functional disability or psychosocial distress." In Italy there are at least 10-15 new cases of sABI per year per 100,000 inhabitants; the estimated prevalence is about 150,000 cases per year. Often, people with sABI present focal neurological deficits, including alterations in strength, sensitivity, coordination and gait.

Most of the rehabilitation protocols for people with sABI are derived from post-stroke studies, caused by lack of evidence on specific rehabilitation of people with sABI. Rehabilitation of people with sABI should begin as soon as possible, to prevent the onset of retractions and decubitus, and to regain joint mobility, strength, and coordination.

OMEGO® (Tyromotion) is a newly developed device used in lower extremity rehabilitation, that provides visual and auditory feedback.

Specifically, OMEGO® contains several games developed to enhance and promote learning behaviors, that simulate activities of daily living. The use of devices such as cycle ergometers is recommended in the rehabilitation of people with sABI; however, there are no studies demonstrating the effect of cycle ergometer training in association with visual feedback.

The purpose of this study is to evaluate, both in people without apparent pathology (hereafter identified as "healthy") and in people with sABI, whether visual feedback during OMEGO® exercise modifies brain connectivity, emotional drive, and lower limb performance during a lower limb-specific motor rehabilitation task.

Enrollment: 24 patients

Sex: All

Ages: 18 to 90 years old

Volunteers: Accepts Healthy Volunteers

Inclusion criteria

• Diagnosis os severe Acquired Brain Injury (sABI)
• Trunk Control Test score greater or equal to 48
• Motricity Index Lower Limb score greater or equal to 18
• Clinical stability
• Patient/Caregiver ability to understand ans sing the informed consent

Exclusion criteria

• Disorder of consciousness (mininally concious state or vegetative state)
• severe visual impairment (central or peripheral, prior or acquired after the scute event)
• presence of severe cognitive impairment
• presence of global aphasia or presence of severe apraxia

Trial design

Primary purpose: Treatment

Allocation: Randomized

Interventional model: Crossover Assignment

Masking: None (Open label)

---

24 participants in 2 patient groups

Group A (no visual feedback-visual feedback)

Experimental group

Description:

Participants in group A (6 patients with sABI and 6 healthy controls), will perform a single rehabilitation session with OMEGO®. In total, they will perform 18 minutes divided as follows: 5 minutes of treatment with OMEGO® without visual feedback, 3 minutes of break, and additional 5 minutes of treatment with OMEGO® plus visual feedback

Treatment:

Device: OMEGO®

Group B (visual feedback-no visual feedback)

Experimental group

Description:

Participants in group B (6 patients with sABI and 6 healthy controls), will perform a single rehabilitation session with OMEGO®. In total, they will perform 18 minutes divided as follows: 5 minutes of treatment with OMEGO® plus visual feedback, 3 minutes of break, and additional 5 minutes of treatment with OMEGO® without visual feedback

Treatment:

Device: OMEGO®